Tag: TULSA
MRI-guided TULSA for localised prostate cancer provides “excellent” functional preservation, yet...
Magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) has demonstrated “excellent” technical feasibility and minimal major morbidity for localised prostate cancer in a recent...
Randomised trial demonstrates MRI-guided TULSA benefit for intermediate-risk prostate cancer
A new randomised controlled trial found that men with localised, intermediate‑risk prostate cancer recovered faster and experienced less short‑term impact on their daily lives...
Five-year outcomes show transurethral ultrasound ablation successful in treatment of prostate...
A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research...
Profound Medical announces new CPT category 1 codes for prostate TULSA
Profound Medical has announced in a press release that, with sponsorship and support from multiple physician specialty societies, the American Medical Association (AMA) has...
